Last update April 19, 2025
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
R-(-)-YM-12617 is also known as Tamsulosin Hydrochloride. Here it is a list of alternative known names::
R-(-)-YM-12617 in other languages or writings:
R-(-)-YM-12617 belongs to this group or family:
Main tradenames from several countries containing R-(-)-YM-12617 in its composition:
| Variable | Value | Unit |
|---|---|---|
| Oral Bioavail. | 90 | % |
| Molecular weight | 445 | daltons |
| Protein Binding | 99 | % |
| VD | 0.2 | l/Kg |
| Tmax | 6 | hours |
| T½ | 10 - 13 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Alpha-1 adrenergic blocker used in benign prostatic hypertrophy and problems of voiding difficulty or obstruction including urolithiasis. Oral administration once daily.
At the date of last update we found no published data on its excretion in breast milk.
Its pharmacokinetic data (very high percentage of protein binding and moderately high molecular weight and volume of distribution) make it unlikely that significant quantities will pass into milk.
Expert authors consider it compatible with breastfeeding by controlling the appearance of irritability, fatigue, nausea or diarrhoea in the infant. (Hale, LactMed)